Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex.
Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex.
复制标题
DOI:
10.1107/s1399004714017775
复制
发表时间:
2014-10
期刊:
影响因子:
--
通讯作者:
Brzozowski AM
中科院分区:
文献类型:
--
作者:
Záková L;Kletvíková E;Lepšík M;Collinsová M;Watson CJ;Turkenburg JP;Jiráček J;Brzozowski AM
[AsnB26]- and [GlyB26]-insulin mutants attain a B26-turn like fold without assistance of chemical modifications. Their structures match the insulin receptor interface and expand the spectrum of insulin conformations. The structural characterization of the insulin–insulin receptor (IR) interaction still lacks the conformation of the crucial B21–B30 insulin region, which must be different from that in its storage forms to ensure effective receptor binding. Here, it is shown that insulin analogues modified by natural amino acids at the TyrB26 site can represent an active form of this hormone. In particular, [AsnB26]-insulin and [GlyB26]-insulin attain a B26-turn-like conformation that differs from that in all known structures of the native hormone. It also matches the receptor interface, avoiding substantial steric clashes. This indicates that insulin may attain a B26-turn-like conformation upon IR binding. Moreover, there is an unexpected, but significant, binding specificity of the AsnB26 mutant for predominantly the metabolic B isoform of the receptor. As it is correlated with the B26 bend of the B-chain of the hormone, the structures of AsnB26 analogues may provide the first structural insight into the structural origins of differential insulin signalling through insulin receptor A and B isoforms.